Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Aneurysm Clinical Trials

A listing of Aneurysm medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (92) clinical trials

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter was approved in the United States (US) under a Humanitarian Device Exemption (HDE) and received CE Mark in 2005. This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety surveillance requirements

Phase N/A

Intracranial aneurysms (IAs) are common cerebrovascular abnormalities. The prevalence of IAs has been reported to be 0.8-2.0% of the population. [1-3] The most common presentation of IAs is subarachnoid hemorrhage (SAH), the annual incidence of which varies by geographic region from 10 to 20 per 100,000. [4 5] SAH is ...

Phase N/A

The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.

Phase N/A

This study is a prospective, multi-center, single-arm study. Subjects requiring treatment for a single de novo unruptured or ruptured (having occurred within the 60 days prior to treatment), wide-neck bifurcating or branching saccular aneurysm will be enrolled.

Phase N/A

pCONus Treatment of Wide Neck Intracranial Aneurysms

Title: pCONus Treatment of Wide Neck Intracranial Aneurysms Acronym: pToWin Device: pCONus Bifurcation Aneurysm Implant Study design: Prospective, multicenter, single-arm clinical investigation Purpose: To assess safety and efficacy of pCONus for the treatment of wide neck bifurcation aneurysms Duration of the study: 48 months Sample size: 100 evaluable patients Number ...

Phase N/A

Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

Title: Diversion-p64. Device: p64 Flow Modulation Device. Study design: Prospective, multicenter, single arm Post Market Clinical Follow-Up Study. Purpose: To assess safety and effectiveness of p64. Study duration: 48 months. Sample Size: 400 patients. Number of sites: > 20. Follow-up intervals: Two independent follow-ups (after 3-6 and 7-12 months) according ...

Phase N/A

European eCLIPS Safety Feasibility and Efficacy Study

The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the eCLIPs Products for the treatment of bifurcation aneurysms. Specifically, procedural success of the eCLIPs Bifurcation Remodelling System (BRS) will be evaluated to determine feasibility of this product and safety will be measured ...

Phase N/A

Valiant Evo US Clinical Trial

The purpose of the Valiant Evo US Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thoracic aortic aneurysm (DTAA) who are candidates for endovascular repair.

Phase

Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms

This is a Prospective single-arm multi-center Registry which aims to collect data to determine the safety and efficacy of one of these marketed coils, namely the Target 360 Ultra coils. This is not an intervention or treatment study. Up to 100 subjects at up to 6 sites will be enrolled. ...

Phase N/A

Medina Embolization Device In Neurovascular Aneurysm Study

A global prospective, multi-center, single-arm, post-market clinical follow-up (PMCF) study conducted to assess the performance of the Medina Embolization Device when used in unruptured and ruptured intracranial aneurysms.

Phase N/A